(symbolic picture)
New Delhi:
A similar mission (vaccination campaign) is going on for Corona virus (Coronavirus). Meanwhile, Quality of India Biotech, Quality of Bharat Biotech (Covaxin) has doctors for its quality treatment. In contrast to The Lancet, more similar (delta version) 65.2 percent than meeting with the same germ as Konkhin. Contrary to sump mic, the manufacturer of biotech in India 77.8.
In the prevention of corona disease (in the case of severe SIMD-19), germs account for 93.4 percent of the patients. The stock is 63.6% positive from Exposure Covid (Asymptomatic COVID 19). The cases of CMOL AEFI were just less than 0.5%. SARS-CoV-2
this also further
,